Therefore, we concluded that the IFI27, TUBB2A and the pathways of NET formation and lupus like immune profile may be the potential immune deregulation mechanism triggered by COVID-19, but further experimental validation in vitro and in vivo is needed. The gene discussed is TUBB2A; the disease is systemic lupus erythematosus.